Shopping Cart
- Remove All
- Your shopping cart is currently empty
Beraprost sodium is a stable and orally active prodrug of PGI2.
Description | Beraprost sodium is a stable and orally active prodrug of PGI2. |
In vitro | Beraprost sodium treatment leads to a significant increase in the number of tube formation, BPS plays an important role on angiogenic activity. |
In vivo | Beraprost sodium oral adminstration can mitigate the development of renal interstitial fibrosis, decrease renal oxidative stress through its potential vasodilation effect, and further prevent renal interstitial fibrosis. |
Molecular Weight | 420.481 |
Formula | C24H29NaO5 |
Cas No. | 496807-11-5 |
Relative Density. | 1.31g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 250 mg/mL (594.57 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.